Late-Onset Ovarian Bleeding After Transvaginal Oocyte Retrieval in a Patient With Suspected Hereditary Hemorrhagic Telangiectasia

نویسندگان

چکیده

Assisted reproductive technology (ART) requires transvaginal oocyte retrieval (TVOR), and ovarian bleeding after TVOR rarely occurs. We present a case of 37-year-old woman (0-gravida) who was diagnosed with possible hemorrhagic telangiectasia (HHT) had history three laparotomies for an inclusion cyst adjacent to the right ovary third operation. HHT is hereditary disease characterized by spontaneous hemorrhage some organs, such as nose, brain, lungs, gastrointestinal tract, liver. She desired ART fertility treatment then abdominal pain swelling five days TVOR. Moreover, both were gradually swollen hematoma. Finally, hemoglobin level deteriorated, necessitating emergency surgery on eighth day. notify physicians that patients may readily develop or without cysts TVOR, although also be associated late-onset bleeding.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

I-30: Late Onset Severe Hemoperitoneum after Transvaginal Oocyte Retrieval: Incidence, Course, and Management

Background Severe ovarian bleeding after transvaginal oocyte retrieval is a rare but potentially life-threatening complication. A late-onset is common and may be associated with an increased risk for ovariectomy. In the present study we analyzed our cases of ovarian bleeding (OB) after oocyte retrieval and compared it with the published cases and studies, including 31 patients. Main outcome mea...

متن کامل

Pulmonary arterial hypertension in a patient with hereditary hemorrhagic telangiectasia.

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by the triad of epistaxis, telangiectasia and vascular malformations. Pulmonary vascular complications associated with this disease include pulmonary arteriovenous malformations (AVM) and, less frequently, pulmonary hypertension (PH). We report the case of a patient who presented multiple pulmonary AVM a...

متن کامل

A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia.

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant inherited disease in which abnormal communications between arteries and veins, the so-called telangiectases, occur in the skin, mucosal surfaces, and solid organs [1]. Small telangiectases on the face may present an important cosmetic problem, but larger lesions can be a source of chronic blood loss, systemic emboli, hypoxemia...

متن کامل

Bleeding risk of cerebrovascular malformations in hereditary hemorrhagic telangiectasia.

OBJECT Hereditary hemorrhagic telangiectasia (HHT) is a rare autosomal-dominant vascular dysplasia with a high prevalence of cerebrovascular malformations (CVMs), mostly manifested as arteriovenous malformations (AVMs). The natural history and bleeding risk of these CVMs is unknown. The authors investigated the risk of bleeding in conjunction with clinical and radiological features in patients ...

متن کامل

Hereditary hemorrhagic telangiectasia/avastin.

This is the first scientific report of hereditary hemorrhagic telangiectasia (HHT) epistaxis treatment by intranasal spraying of the vascular endothelial growth factor (VEGF) inhibitor bevacizumab (Avastin). Epistaxis in patients with HHT is a morbid, mortal condition that is difficult and unpleasant to manage. Nasal telangiectasia growth is modulated by VEGF, which is elevated in HHT patients....

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Cureus

سال: 2023

ISSN: ['2168-8184']

DOI: https://doi.org/10.7759/cureus.45657